1. Home
  2. DYAI vs PCLA Comparison

DYAI vs PCLA Comparison

Compare DYAI & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • PCLA
  • Stock Information
  • Founded
  • DYAI 1979
  • PCLA 2008
  • Country
  • DYAI United States
  • PCLA Japan
  • Employees
  • DYAI N/A
  • PCLA N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • PCLA Building Products
  • Sector
  • DYAI Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • DYAI Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • DYAI 29.6M
  • PCLA 32.3M
  • IPO Year
  • DYAI 2004
  • PCLA 2025
  • Fundamental
  • Price
  • DYAI $0.97
  • PCLA $1.85
  • Analyst Decision
  • DYAI Strong Buy
  • PCLA
  • Analyst Count
  • DYAI 1
  • PCLA 0
  • Target Price
  • DYAI $6.00
  • PCLA N/A
  • AVG Volume (30 Days)
  • DYAI 41.0K
  • PCLA 1.9M
  • Earning Date
  • DYAI 08-12-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • PCLA N/A
  • EPS Growth
  • DYAI N/A
  • PCLA N/A
  • EPS
  • DYAI N/A
  • PCLA N/A
  • Revenue
  • DYAI $3,554,344.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • DYAI $22.56
  • PCLA N/A
  • Revenue Next Year
  • DYAI $30.95
  • PCLA N/A
  • P/E Ratio
  • DYAI N/A
  • PCLA N/A
  • Revenue Growth
  • DYAI 57.59
  • PCLA 40.19
  • 52 Week Low
  • DYAI $0.91
  • PCLA $0.37
  • 52 Week High
  • DYAI $2.20
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 48.57
  • PCLA N/A
  • Support Level
  • DYAI $0.95
  • PCLA N/A
  • Resistance Level
  • DYAI $1.06
  • PCLA N/A
  • Average True Range (ATR)
  • DYAI 0.05
  • PCLA 0.00
  • MACD
  • DYAI 0.01
  • PCLA 0.00
  • Stochastic Oscillator
  • DYAI 53.33
  • PCLA 0.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: